Covaxin: Nearly One-third Participants Reported Adverse Events, Says New Study

Nearly a third of participants who took Covaxin, the Covid-19 vaccine made by Bharat Biotech Ltd, reported adverse events of special interest (AESI), with females and those with allergies at higher risk, says a new study published on SpringerLink

Related Keywords

India ,Banaras ,Uttar Pradesh ,Bharat ,Sankha Shubhra Chakrabarti ,Indian Council Of Medical Research ,Bharat Biotech Ltd ,National Institute Of Virology ,Banaras Hindu University ,Guillain Barre Syndrome ,Bharat Biotech ,Indian Council ,Medical Research ,National Institute ,